Microdosing

Microdosing GLP-1s means using doses lower than the standard titration schedule — for example, staying at a starter dose long-term, or using small amounts to manage maintenance or minimize side effects. It’s a widely discussed community practice, and one to understand carefully because the enthusiasm around it runs ahead of the evidence.

Why people do it

The motivations are understandable:

• Maintenance — staying at the lowest dose that holds their weight and keeps food noise quiet, rather than the maximum.
• Side-effect control — a lower dose often means less nausea and fewer GI effects.
• Cost and supply — stretching medication further during shortages or expensive stretches.

Some of this overlaps with legitimate, prescriber-directed practice: settling on a lower maintenance dose is a real and reasonable strategy.

The honest caveats

Where “microdosing” gets risky is when it becomes DIY:

• It’s largely unstudied. The trials that established these drugs used defined dose schedules; low-dose, long-term, or self-adjusted regimens don’t have that evidence base. “It works for people online” isn’t the same as demonstrated.
• Self-measuring invites errors. Microdosing often means drawing small amounts from compounded multi-dose vials — precisely the setup where dangerous dosing mistakes have happened.
• Off-label and unsupervised. Adjusting your own dose outside a prescriber’s plan removes the safety checks the schedule is designed around.

The reasonable version

If a lower dose appeals — for maintenance, tolerability, or cost — the sound path is to raise it with your prescriber and adjust under their guidance, with accurate dosing and a log. That captures most of the benefit people chase, without the self-experimentation risk. Microdosing as a supervised strategy: defensible. Microdosing as solo guesswork with a syringe: not.